Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Publications are now described as automatically filled from PubMed and may not all pertain to the study, and the page revision has been updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:56:50.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The banner about government funding status and operating status has been removed from the page.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:22.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the Study Details page content appears unchanged, including eligibility criteria and locations.
    Difference
    0.4%
    Check dated 2025-11-03T21:00:23.000Z thumbnail image
  5. Check
    64 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T05:23:20.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a new version tag (v3.1.0). - Removed a specific resource (Ovarian cancer) and an older revision tag (v3.0.2).
    Difference
    0.3%
    Check dated 2025-09-29T03:02:22.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2. Removed the 'Back to Top' element; no changes to core content, pricing, stock, or time slots.
    Difference
    0.2%
    Check dated 2025-09-14T18:59:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.